MoonLake Immunotherapeutics - CLASS A ORD (MLTX)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / CLASS A ORD
Number of holders
129
Total Shares
58.3M
Shares change
+2.51M
Total reported value, excl. options
$3.52B
Value change
+$159M
Put/Call ratio
1.04
Number of buys
84
Number of sells
-59
Price
$60.39
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.